S Fujinaga
Overview
Explore the profile of S Fujinaga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kojima S, Takizawa S, Tamura S, Fujinaga S, Benno Y, Nakase T
Biosci Biotechnol Biochem
. 2016 Jun;
57(1):119-20.
PMID: 27316884
No abstract available.
2.
Fujinaga S, Watanabe T, Endo A, Hirano D, Ohtomo Y, Shimizu T, et al.
Clin Nephrol
. 2011 Nov;
76(6):504-6.
PMID: 22105456
No abstract available.
3.
Fujinaga S, Nishizaki N, Hirano D, Kanai H, Suzuki M, Ohtomo Y, et al.
Clin Nephrol
. 2010 Dec;
75(1):89-90.
PMID: 21176756
No abstract available.
4.
Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, et al.
Clin Nephrol
. 2010 Sep;
74(4):303-7.
PMID: 20875383
A multivariate analysis [4] revealed that the presence of crescent formation on initial biopsy irrespective of type of membranoproliferative glomerulonephritis (MPGN) was independently associated not only with end-stage renal disease...
5.
Narikiyo T, Miura H, Fujinaga S, Ohmori A
Opt Lett
. 2009 Nov;
21(19):1562-3.
PMID: 19881725
Nd:YAG laser light beams from three oscillators were separately condensed and then combined at a processing point to enhance the processing ability of the laser system. In this system one...
6.
Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, et al.
Clin Nephrol
. 2009 Oct;
72(4):268-73.
PMID: 19825332
Background: Mycophenolate mofetil (MMF) is being used increasingly in children with steroid-dependent nephrotic syndrome (SDNS). However, there is limited information on the optimal therapeutic range for mycophenolic acid (MPA), the...
7.
Fujinaga S, Ohtomo Y, Someya T, Shimizu T, Yamashiro Y, Kaneko K
Clin Nephrol
. 2008 Jan;
69(2):84-9.
PMID: 18218301
Background: A recent study on renal transplant patients has shown that a single dose of cyclosporine (CsA) has added the advantage of decreasing dosages and adverse effects, while maintaining graft...
8.
Fujinaga S, Ohtomo Y, Someya T, Shimizu T, Yamashiro Y, Kaneko K
Clin Nephrol
. 2008 Jan;
68(6):428-30.
PMID: 18184528
No abstract available.
9.
Fujinaga S, Kaneko K, Muto T, Ohtomo Y, Murakami H, Yamashiro Y
Arch Dis Child
. 2006 May;
91(8):666-70.
PMID: 16670120
Background: Cyclosporine A (CsA) has been widely used in children with steroid dependent and steroid resistant nephrotic syndrome (NS) because of its efficacy in relieving these patients from systemic side...
10.
Kaneko K, Tuchiya K, Fujinaga S, Kawamura R, Ohtomo Y, Shimizu T, et al.
Clin Nephrol
. 2003 Jan;
58(6):393-7.
PMID: 12508959
Aims: In view of the conflicting evidence of helper T cell type 1 (Th1) or type 2 (Th2) pattern of cytokine synthesis in childhood idiopathic nephrotic syndrome (INS) this study...